Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction

被引:12
作者
García-Echeverría, C [1 ]
Furet, P [1 ]
Chène, P [1 ]
机构
[1] Novartis Pharma Inc, Oncol Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/S0960-894X(01)00394-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of cell-membrane translocating sequences for intracellular delivery of peptides can be a powerful approach to validate drug discovery targets in cellular settings. To accomplish this, a protocol has been implemented to couple the antennapedia third helix (residues 43-58) to a potent antagonist of the p53/hdm2 protein-protein interaction without affecting its in vitro inhibitory activity. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2161 / 2164
页数:4
相关论文
共 21 条
[1]  
Atherton E., 1989, SOLID PHASE PEPTIDE
[2]  
ATHERTON E, 1987, PEPTIDES ANAL SYNTHE, V9, P1
[3]   Molecular characterization of the hdm2-p53 interaction [J].
Bottger, A ;
Bottger, V ;
GarciaEcheverria, C ;
Chene, P ;
Hochkeppel, HK ;
Sampson, W ;
Ang, K ;
Howard, SF ;
Picksley, SM ;
Lane, DP .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 269 (05) :744-756
[4]  
Bottger V, 1996, ONCOGENE, V13, P2141
[5]   MOLECULAR ANALYSIS AND CHROMOSOMAL MAPPING OF AMPLIFIED GENES ISOLATED FROM A TRANSFORMED MOUSE 3T3-CELL LINE [J].
CAHILLYSNYDER, L ;
YANGFENG, T ;
FRANCKE, U ;
GEORGE, DL .
SOMATIC CELL AND MOLECULAR GENETICS, 1987, 13 (03) :235-244
[6]   1-HYDROXY-7-AZABENZOTRIAZOLE - AN EFFICIENT PEPTIDE COUPLING ADDITIVE [J].
CARPINO, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (10) :4397-4398
[7]   A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines [J].
Chène, P ;
Fuchs, J ;
Bohn, J ;
García-Echeverría, C ;
Furet, P ;
Fabbro, D .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 299 (01) :245-253
[8]   Trojan peptides: the penetratin system for intracellular delivery [J].
Derossi, D ;
Chassaing, G ;
Prochiantz, A .
TRENDS IN CELL BIOLOGY, 1998, 8 (02) :84-87
[9]  
DIDOMENICO R, Patent No. 947494
[10]   THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH [J].
FINLAY, CA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :301-306